tiprankstipranks
Trending News
More News >
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
US Market

Aurinia Pharmaceuticals (AUPH) Income Statement

Compare
2,108 Followers

Aurinia Pharmaceuticals Income Statement

Last quarter (Q4 2025), Aurinia Pharmaceuticals's total revenue was $77.11M, an increase of 28.81% from the same quarter last year. In Q4, Aurinia Pharmaceuticals's net income was $210.79M. See Aurinia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 283.06M$ 235.13M$ 175.51M$ 134.03M$ 45.60M
Gross Profit
$ 250.39M$ 206.88M$ 161.37M$ 128.37M$ 44.51M
Operating Expenses
$ 145.48M$ 211.57M$ 253.06M$ 239.84M$ 225.25M
Depreciation and Amortization
$ 9.27M$ 19.45M$ 11.65M$ 2.71M$ 2.76M
EBITDA
$ 127.76M$ 31.73M$ -63.05M$ -103.65M$ -177.44M
Operating Income
$ 104.91M$ -4.69M$ -91.69M$ -111.47M$ -180.74M
Other Income/Expenses
$ 9.24M$ 12.13M$ 14.22M$ 5.12M$ 529.00K
Pretax Income
$ 114.16M$ 7.45M$ -77.47M$ -106.35M$ -180.21M
Net Income
$ 287.20M$ 5.75M$ -78.02M$ -108.18M$ -180.97M
Per Share Metrics
Basic EPS
$ 2.14$ 0.04$ -0.54$ -0.76$ -1.40
Diluted EPS
$ 2.07$ 0.04$ -0.54$ -0.76$ -1.40
Weighted Average Shares Outstanding
134.37M 143.06M 143.24M 141.91M 129.37M
Weighted Average Shares Outstanding (Diluted)
138.70M 146.19M 143.24M 141.91M 129.37M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History